Rossby Financial LCC Lowers Position in HCA Healthcare, Inc. $HCA

Rossby Financial LCC reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 11.6% in the second quarter, HoldingsChannel reports. The institutional investor owned 907 shares of the company’s stock after selling 119 shares during the quarter. Rossby Financial LCC’s holdings in HCA Healthcare were worth $347,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cheviot Value Management LLC purchased a new stake in HCA Healthcare in the 1st quarter valued at $26,000. Saudi Central Bank purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at $26,000. WPG Advisers LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at $27,000. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at $27,000. Finally, Chung Wu Investment Group LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at $27,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Royal Bank Of Canada raised their target price on HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a research report on Monday. Raymond James Financial set a $525.00 price target on HCA Healthcare in a research note on Monday. Bank of America increased their price target on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday. The Goldman Sachs Group increased their price target on HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research note on Monday. Finally, Mizuho increased their price target on HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research note on Monday. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $473.53.

HCA Healthcare Stock Down 0.3%

Shares of NYSE HCA opened at $466.34 on Wednesday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $469.18. The business has a 50-day simple moving average of $417.60 and a two-hundred day simple moving average of $384.15. The company has a market cap of $109.12 billion, a P/E ratio of 18.03, a P/E/G ratio of 1.43 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter last year, the company earned $4.90 EPS. The firm’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.